|
CN111693623A
|
|
Method for determining genotoxic impurities in milrinone by high performance liquid chromatography
|
|
CN111624291A
|
|
Method for determining content of impurities in epristeride tablets by using HPLC (high performance liquid chromatography)
|
|
CN111579688A
|
|
Method for determining content of enantiomer in dapoxetine hydrochloride
|
|
CN111579689A
|
|
Method for measuring content of dimethyl sulfate in clopidogrel hydrogen sulfate
|
|
CN111362999A
|
|
Epiletin impurity and preparation method and application thereof
|
|
CN111170847A
|
|
Novel method for preparing drotaverine hydrochloride intermediate
|
|
CN110256519A
|
|
The method of one kettle way preparation uliprista acetate
|
|
CN109517027A
|
|
A kind of preparation method of danazol
|
|
CN109593058A
|
|
A kind of preparation method of Ebastine
|
|
CN109796351A
|
|
A kind of novel preparation method of drotaverine hydrochloride intermediate
|
|
CN108014087A
|
|
A kind of preparation method of sertraline hydrochloride capsules
|
|
CN108267520A
|
|
A kind of method that the residual solvent dichloroethanes in special butanone production technology is detected using fid detector
|
|
CN108195962A
|
|
A kind of inspection separation method of RMI 9918 in relation to substance
|
|
CN108057026A
|
|
A kind of preparation method of benzene sulphur bepotastine tablet
|
|
CN108164454A
|
|
A kind of new preparation process of felodipine
|
|
CN108456202A
|
|
A kind of Azilsartan preparation method of low amide impurities content
|
|
CN107513093A
|
|
The preparation method of epristeride intermediate and preparation method thereof, epristeride
|
|
CN107488206A
|
|
Crystal formation A, crystal formation B of epristeride and preparation method thereof, pharmaceutical composition
|
|
CN106706789A
|
|
Method for detecting related substances in drotaverine hydrochloride injection by high performance liquid chromatography
|
|
CN105669475A
|
|
Preparation method of dapoxetine and dapoxetine hydrochloride
|
